NDC 68151-2298

Danazol

Danazol

Danazol is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Carilion Materials Management. The primary component is Danazol.

Product ID68151-2298_79371e5b-3968-4c5d-9ef7-c78e92f64080
NDC68151-2298
Product TypeHuman Prescription Drug
Proprietary NameDanazol
Generic NameDanazol
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2005-09-28
Marketing CategoryANDA / ANDA
Application NumberANDA077246
Labeler NameCarilion Materials Management
Substance NameDANAZOL
Active Ingredient Strength200 mg/1
Pharm ClassesAndrogen Receptor Agonists [MoA],Androstanes [CS],Androgen [EPC]
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 68151-2298-0

1 CAPSULE in 1 PACKAGE (68151-2298-0)
Marketing Start Date2005-09-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68151-2298-0 [68151229800]

Danazol CAPSULE
Marketing CategoryANDA
Application NumberANDA077246
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2005-09-28
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
DANAZOL200 mg/1

OpenFDA Data

SPL SET ID:35a21f89-cf5f-4e8b-8400-3ef7023bc49c
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197555
  • Pharmacological Class

    • Androgen Receptor Agonists [MoA]
    • Androstanes [CS]
    • Androgen [EPC]

    NDC Crossover Matching brand name "Danazol" or generic name "Danazol"

    NDCBrand NameGeneric Name
    0527-1368DanazolDanazol
    0527-1369DanazolDanazol
    0527-1392DanazolDanazol
    0555-0633DanazolDanazol
    0555-0634DanazolDanazol
    0555-0635DanazolDanazol
    42291-243DanazolDanazol
    68151-2298DanazolDanazol
    71205-861DanazolDanazol
    71205-862DanazolDanazol

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.